{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T00:08:40Z","timestamp":1790208520116,"version":"4.1.0"},"reference-count":95,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2022,8,25]],"date-time":"2022-08-25T00:00:00Z","timestamp":1661385600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2022,8,25]],"date-time":"2022-08-25T00:00:00Z","timestamp":1661385600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"funder":[{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["PI21\/01248"],"award-info":[{"award-number":["PI21\/01248"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["PT20\/000127"],"award-info":[{"award-number":["PT20\/000127"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["CD20\/00083"],"award-info":[{"award-number":["CD20\/00083"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Consejer\u00eda de Salud de Junta de Andaluc\u00eda","award":["PI-0310-2018"],"award-info":[{"award-number":["PI-0310-2018"]}]},{"name":"Junta de Andalucia","award":["POSTDOC_21_00780"],"award-info":[{"award-number":["POSTDOC_21_00780"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Drug Saf"],"published-print":{"date-parts":[[2022,11]]},"DOI":"10.1007\/s40264-022-01224-w","type":"journal-article","created":{"date-parts":[[2022,8,25]],"date-time":"2022-08-25T06:03:36Z","timestamp":1661407416000},"page":"1329-1348","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":22,"title":["Therapeutic Management of Idiosyncratic Drug-Induced Liver Injury and Acetaminophen Hepatotoxicity in the Paediatric Population: A Systematic Review"],"prefix":"10.1007","volume":"45","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3030-3972","authenticated-orcid":false,"given":"Hao","family":"Niu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7341-9174","authenticated-orcid":false,"given":"Edmond","family":"Atallah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6271-0604","authenticated-orcid":false,"given":"Ismael","family":"Alvarez-Alvarez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0471-6658","authenticated-orcid":false,"given":"Inmaculada","family":"Medina-Caliz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3924-4830","authenticated-orcid":false,"given":"Guruprasad P.","family":"Aithal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0794-2741","authenticated-orcid":false,"given":"Cigdem","family":"Arikan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1565-0757","authenticated-orcid":false,"given":"Raul J.","family":"Andrade","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9586-4896","authenticated-orcid":false,"given":"M. Isabel","family":"Lucena","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,8,25]]},"reference":[{"issue":"1","key":"1224_CR1","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1038\/s41572-019-0105-0","volume":"5","author":"RJ Andrade","year":"2019","unstructured":"Andrade RJ, Chalasani N, Bjornsson ES, Suzuki A, Kullak-Ublick GA, Watkins PB, et al. Drug-induced liver injury. Nat Rev Dis Primers. 2019;5(1):58. https:\/\/doi.org\/10.1038\/s41572-019-0105-0.","journal-title":"Nat Rev Dis Primers"},{"issue":"12","key":"1224_CR2","doi-asserted-by":"publisher","first-page":"1157","DOI":"10.1056\/NEJMra035092","volume":"349","author":"GL Kearns","year":"2003","unstructured":"Kearns GL, Abdel-Rahman SM, Alander SW, Blowey DL, Leeder JS, Kauffman RE. Developmental pharmacology\u2013drug disposition, action, and therapy in infants and children. N Engl J Med. 2003;349(12):1157\u201367. https:\/\/doi.org\/10.1056\/NEJMra035092.","journal-title":"N Engl J Med"},{"issue":"3","key":"1224_CR3","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1111\/bcp.12267","volume":"79","author":"HK Batchelor","year":"2015","unstructured":"Batchelor HK, Marriott JF. Paediatric pharmacokinetics: key considerations. Br J Clin Pharmacol. 2015;79(3):395\u2013404. https:\/\/doi.org\/10.1111\/bcp.12267.","journal-title":"Br J Clin Pharmacol"},{"issue":"Suppl 10","key":"1224_CR4","doi-asserted-by":"publisher","first-page":"S10","DOI":"10.1002\/jcph.1284","volume":"58","author":"J van den Anker","year":"2018","unstructured":"van den Anker J, Reed MD, Allegaert K, Kearns GL. Developmental changes in pharmacokinetics and pharmacodynamics. J Clin Pharmacol. 2018;58(Suppl 10):S10\u201325. https:\/\/doi.org\/10.1002\/jcph.1284.","journal-title":"J Clin Pharmacol"},{"issue":"5","key":"1224_CR5","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1111\/j.1365-2125.2010.03754.x","volume":"70","author":"C Ferrajolo","year":"2010","unstructured":"Ferrajolo C, Capuano A, Verhamme KM, Schuemie M, Rossi F, Stricker BH, et al. Drug-induced hepatic injury in children: a case\/non-case study of suspected adverse drug reactions in VigiBase. Br J Clin Pharmacol. 2010;70(5):721\u20138. https:\/\/doi.org\/10.1111\/j.1365-2125.2010.03754.x.","journal-title":"Br J Clin Pharmacol"},{"issue":"1","key":"1224_CR6","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1016\/j.jhep.2021.01.029","volume":"75","author":"C Stephens","year":"2021","unstructured":"Stephens C, Robles-Diaz M, Medina-Caliz I, Garcia-Cortes M, Ortega-Alonso A, Sanabria-Cabrera J, et al. Comprehensive analysis and insights gained from long-term experience of the Spanish DILI Registry. J Hepatol. 2021;75(1):86\u201397. https:\/\/doi.org\/10.1016\/j.jhep.2021.01.029.","journal-title":"J Hepatol"},{"issue":"3","key":"1224_CR7","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1016\/j.jceh.2020.11.002","volume":"11","author":"H Devarbhavi","year":"2021","unstructured":"Devarbhavi H, Joseph T, Sunil Kumar N, Rathi C, Thomas V, Prasad Singh S, et al. The Indian Network of drug-induced liver injury: etiology, clinical features, outcome and prognostic markers in 1288 patients. J Clin Exp Hepatol. 2021;11(3):288\u201398. https:\/\/doi.org\/10.1016\/j.jceh.2020.11.002.","journal-title":"J Clin Exp Hepatol"},{"issue":"5","key":"1224_CR8","doi-asserted-by":"publisher","first-page":"652","DOI":"10.1016\/j.jpeds.2005.12.051","volume":"148","author":"RH Squires","year":"2006","unstructured":"Squires RH, Shneider BL, Bucuvalas J, Alonso E, Sokol RJ, Narkewicz MR, et al. Acute liver failure in children: the first 348 patients in the pediatric acute liver failure study group. J Pediatr. 2006;148(5):652\u20138. https:\/\/doi.org\/10.1016\/j.jpeds.2005.12.051.","journal-title":"J Pediatr"},{"issue":"6","key":"1224_CR9","doi-asserted-by":"publisher","first-page":"1222","DOI":"10.1016\/j.jhep.2019.02.014","volume":"70","author":"European Association for the Study of the Liver","year":"2019","unstructured":"European Association for the Study of the Liver. EASL clinical practice guidelines: drug-induced liver injury. J Hepatol. 2019;70(6):1222\u201361. https:\/\/doi.org\/10.1016\/j.jhep.2019.02.014.","journal-title":"J Hepatol"},{"issue":"4","key":"1224_CR10","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1016\/j.cld.2018.06.009","volume":"22","author":"JE Squires","year":"2018","unstructured":"Squires JE, McKiernan P, Squires RH. Acute liver failure: an update. Clin Liver Dis. 2018;22(4):773\u2013805. https:\/\/doi.org\/10.1016\/j.cld.2018.06.009.","journal-title":"Clin Liver Dis"},{"issue":"4","key":"1224_CR11","doi-asserted-by":"publisher","first-page":"175","DOI":"10.5694\/mja2.50428","volume":"212","author":"AL Chiew","year":"2020","unstructured":"Chiew AL, Reith D, Pomerleau A, Wong A, Isoardi KZ, Soderstrom J, et al. Updated guidelines for the management of paracetamol poisoning in Australia and New Zealand. Med J Aust. 2020;212(4):175\u201383. https:\/\/doi.org\/10.5694\/mja2.50428.","journal-title":"Med J Aust"},{"key":"1224_CR12","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.n71","volume":"372","author":"MJ Page","year":"2021","unstructured":"Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021;372: n71. https:\/\/doi.org\/10.1136\/bmj.n71.","journal-title":"BMJ"},{"issue":"1","key":"1224_CR13","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1186\/s13643-016-0384-4","volume":"5","author":"M Ouzzani","year":"2016","unstructured":"Ouzzani M, Hammady H, Fedorowicz Z, Elmagarmid A. Rayyan\u2014a web and mobile app for systematic reviews. Syst Rev. 2016;5(1):210. https:\/\/doi.org\/10.1186\/s13643-016-0384-4.","journal-title":"Syst Rev"},{"issue":"6","key":"1224_CR14","doi-asserted-by":"publisher","first-page":"806","DOI":"10.1038\/clpt.2011.58","volume":"89","author":"GP Aithal","year":"2011","unstructured":"Aithal GP, Watkins PB, Andrade RJ, Larrey D, Molokhia M, Takikawa H, et al. Case definition and phenotype standardization in drug-induced liver injury. Clin Pharmacol Ther. 2011;89(6):806\u201315. https:\/\/doi.org\/10.1038\/clpt.2011.58.","journal-title":"Clin Pharmacol Ther"},{"key":"1224_CR15","doi-asserted-by":"crossref","unstructured":"Moola S, Munn Z, Tufanaru C, Aromataris E, Sears K, Sfetcu R, et al. Chapter 7: Systematic reviews of etiology and risk. JBI manual for evidence synthesis. 2020. https:\/\/synthesismanual.jbi.global. Accessed 9 July 2022.","DOI":"10.46658\/JBIMES-20-08"},{"key":"1224_CR16","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.i4919","volume":"355","author":"JA Sterne","year":"2016","unstructured":"Sterne JA, Hernan MA, Reeves BC, Savovic J, Berkman ND, Viswanathan M, et al. ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions. BMJ. 2016;355: i4919. https:\/\/doi.org\/10.1136\/bmj.i4919.","journal-title":"BMJ"},{"key":"1224_CR17","volume-title":"Guideline on good pharmacovigilance practices (GVP)","author":"European Medicines Agency and Heads of Medicines Agencies","year":"2018","unstructured":"European Medicines Agency and Heads of Medicines Agencies. Guideline on good pharmacovigilance practices (GVP). Amsterdam: European Medicines Agency; 2018."},{"issue":"5","key":"1224_CR18","doi-asserted-by":"publisher","DOI":"10.1136\/bcr-2021-245406","volume":"15","author":"K Raghu","year":"2022","unstructured":"Raghu K, Berry MJ. Acute liver failure secondary to therapeutic paracetamol dosing in an extremely preterm neonate. BMJ Case Rep. 2022;15(5): e245406. https:\/\/doi.org\/10.1136\/bcr-2021-245406.","journal-title":"BMJ Case Rep"},{"issue":"2","key":"1224_CR19","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1038\/sj.jp.7211641","volume":"27","author":"L Walls","year":"2007","unstructured":"Walls L, Baker CF, Sarkar S. Acetaminophen-induced hepatic failure with encephalopathy in a newborn. J Perinatol. 2007;27(2):133\u20135. https:\/\/doi.org\/10.1038\/sj.jp.7211641.","journal-title":"J Perinatol"},{"issue":"12","key":"1224_CR20","doi-asserted-by":"publisher","first-page":"824","DOI":"10.1097\/01.pec.0000148032.06964.b0","volume":"20","author":"AE Mu\u00f1iz","year":"2004","unstructured":"Mu\u00f1iz AE, Rose SR 2nd, Liner SR, Foster RL. Unsuspected acetaminophen toxicity in a 58-day-old infant. Pediatr Emerg Care. 2004;20(12):824\u20138. https:\/\/doi.org\/10.1097\/01.pec.0000148032.06964.b0.","journal-title":"Pediatr Emerg Care"},{"issue":"4","key":"1224_CR21","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1179\/146532808X375495","volume":"28","author":"K Ebenezer","year":"2008","unstructured":"Ebenezer K, Agarwal I, Fleming D. Acute hepatic failure in an infant caused by acetaminophen (paracetamol) toxicity. Ann Trop Paediatr. 2008;28(4):301\u20133. https:\/\/doi.org\/10.1179\/146532808X375495.","journal-title":"Ann Trop Paediatr"},{"key":"1224_CR22","doi-asserted-by":"publisher","DOI":"10.1155\/2009\/673269","volume":"2009","author":"KL Hon","year":"2009","unstructured":"Hon KL, Leung AK. Be careful, mom and doc: hepatotoxicity associated with prescribed medications in young infants. Int J Pediatr. 2009;2009: 673269. https:\/\/doi.org\/10.1155\/2009\/673269.","journal-title":"Int J Pediatr"},{"issue":"3","key":"1224_CR23","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1136\/adc.2010.192005","volume":"96","author":"RM Beringer","year":"2011","unstructured":"Beringer RM, Thompson JP, Parry S, Stoddart PA. Intravenous paracetamol overdose: two case reports and a change to national treatment guidelines. Arch Dis Child. 2011;96(3):307\u20138. https:\/\/doi.org\/10.1136\/adc.2010.192005.","journal-title":"Arch Dis Child"},{"issue":"2","key":"1224_CR24","doi-asserted-by":"publisher","first-page":"e494","DOI":"10.1542\/peds.2010-1965","volume":"127","author":"F Savino","year":"2011","unstructured":"Savino F, Lupica MM, Tarasco V, Locatelli E, Garazzino S, Tovo PA. Fulminant hepatitis after 10 days of acetaminophen treatment at recommended dosage in an infant. Pediatrics. 2011;127(2):e494\u20137. https:\/\/doi.org\/10.1542\/peds.2010-1965.","journal-title":"Pediatrics"},{"issue":"2","key":"1224_CR25","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1016\/j.arcped.2021.11.006","volume":"29","author":"U Karaarslan","year":"2022","unstructured":"Karaarslan U, Colak M, Topal S, Atakul G, Soydan E, Caglar A, et al. The association between N-acetylcysteine treatment and hepatic healing in patients with non-acetaminophen-induced liver injury in pediatric intensive care: a single-center retrospective study. Arch Pediatr. 2022;29(2):140\u20134. https:\/\/doi.org\/10.1016\/j.arcped.2021.11.006.","journal-title":"Arch Pediatr"},{"issue":"2","key":"1224_CR26","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1055\/s-0040-1712158","volume":"10","author":"P Awasthi","year":"2021","unstructured":"Awasthi P, Jindal A, Sharma Y, Williams V, Ravikumar N, Nallasamy K, et al. Continuous venovenous hemofiltration as a rescue therapy for severe acetaminophen toxicity in a toddler. J Pediatr Intensive Care. 2021;10(2):159\u201361. https:\/\/doi.org\/10.1055\/s-0040-1712158.","journal-title":"J Pediatr Intensive Care"},{"issue":"5","key":"1224_CR27","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1001\/archpedi.1984.02140430006003","volume":"138","author":"BH Rumack","year":"1984","unstructured":"Rumack BH. Acetaminophen overdose in young children. Treatment and effects of alcohol and other additional ingestants in 417 cases. Am J Dis Child. 1984;138(5):428\u201333. https:\/\/doi.org\/10.1001\/archpedi.1984.02140430006003.","journal-title":"Am J Dis Child"},{"issue":"10","key":"1224_CR28","doi-asserted-by":"publisher","first-page":"1139","DOI":"10.1016\/j.dld.2017.05.026","volume":"49","author":"A Di Giorgio","year":"2017","unstructured":"Di Giorgio A, Sonzogni A, Picciche A, Alessio G, Bonanomi E, Colledan M, et al. Successful management of acute liver failure in Italian children: a 16-year experience at a referral centre for paediatric liver transplantation. Dig Liver Dis. 2017;49(10):1139\u201345. https:\/\/doi.org\/10.1016\/j.dld.2017.05.026.","journal-title":"Dig Liver Dis"},{"issue":"10","key":"1224_CR29","first-page":"997","volume":"57","author":"M Brenner","year":"2019","unstructured":"Brenner M, Zosel A, Stanton M, Gummin D. An unusual case of severe pediatric acetaminophen overdose treated with increased dose N-acetylcysteine. Clin Toxicol. 2019;57(10):997.","journal-title":"Clin Toxicol"},{"issue":"7","key":"1224_CR30","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1007\/BF02074828","volume":"154","author":"B Simma","year":"1995","unstructured":"Simma B, Meister B, Deutsch J, Sperl W, Fend F, Ofner D, et al. Fulminant hepatic failure in a child as a potential adverse effect of trimethoprim-sulphamethoxazole. Eur J Pediatr. 1995;154(7):530\u20133. https:\/\/doi.org\/10.1007\/BF02074828.","journal-title":"Eur J Pediatr"},{"key":"1224_CR31","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/s0022-3476(00)90064-7","volume":"136","author":"A Chawla","year":"2000","unstructured":"Chawla A, Kahn E, Yunis EJ, Daum F. Rapidly progressive cholestasis: an unusual reaction to amoxicillin\/clavulanate acid therapy in a child. J Pediatr. 2000;136:121\u20133. https:\/\/doi.org\/10.1016\/s0022-3476(00)90064-7.","journal-title":"J Pediatr"},{"issue":"4","key":"1224_CR32","doi-asserted-by":"publisher","first-page":"273","DOI":"10.5223\/pghn.2013.16.4.273","volume":"16","author":"HJ Cho","year":"2013","unstructured":"Cho HJ, Jwa HJ, Kim KS, Gang DY, Kim JY. Urosodeoxycholic acid therapy in a child with trimethoprim-sulfamethoxazole-induced vanishing bile duct syndrome. Pediatr Gastroenterol Hepatol Nutr. 2013;16(4):273\u20138. https:\/\/doi.org\/10.5223\/pghn.2013.16.4.273.","journal-title":"Pediatr Gastroenterol Hepatol Nutr."},{"issue":"2","key":"1224_CR33","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1159\/000324506","volume":"222","author":"T Hubiche","year":"2011","unstructured":"Hubiche T, Milpied B, Cazeau C, Taieb A, Leaute-Labreze C. Association of immunologically confirmed delayed drug reaction and human herpesvirus 6 viremia in a pediatric case of drug-induced hypersensitivity syndrome. Dermatology. 2011;222(2):140\u20131. https:\/\/doi.org\/10.1159\/000324506.","journal-title":"Dermatology"},{"issue":"4","key":"1224_CR34","doi-asserted-by":"publisher","first-page":"1090","DOI":"10.1111\/bjd.13512","volume":"172","author":"J Ahluwalia","year":"2015","unstructured":"Ahluwalia J, Abuabara K, Perman MJ, Yan AC. Human herpesvirus 6 involvement in paediatric drug hypersensitivity syndrome. Br J Dermatol. 2015;172(4):1090\u20135. https:\/\/doi.org\/10.1111\/bjd.13512.","journal-title":"Br J Dermatol"},{"issue":"6","key":"1224_CR35","doi-asserted-by":"publisher","first-page":"e391","DOI":"10.1111\/pde.13607","volume":"35","author":"M Maarouf","year":"2018","unstructured":"Maarouf M, Wickenheiser M, Krase JM, Wolter S, Shi VY. Trimethoprim-sulfamethoxazole-induced drug reaction with eosinophilia and systemic symptoms in a child with congenital renal disease. Pediatr Dermatol. 2018;35(6):e391\u20132. https:\/\/doi.org\/10.1111\/pde.13607.","journal-title":"Pediatr Dermatol"},{"issue":"6","key":"1224_CR36","doi-asserted-by":"publisher","first-page":"1921","DOI":"10.1016\/j.transproceed.2008.05.075","volume":"40","author":"G Novelli","year":"2008","unstructured":"Novelli G, Rossi M, Morabito V, Pugliese F, Ruberto F, Perrella SM, et al. Pediatric acute liver failure with molecular adsorbent recirculating system treatment. Transpl Proc. 2008;40(6):1921\u20134. https:\/\/doi.org\/10.1016\/j.transproceed.2008.05.075.","journal-title":"Transpl Proc"},{"issue":"3","key":"1224_CR37","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1002\/lt.24037","volume":"21","author":"WS Lexmond","year":"2015","unstructured":"Lexmond WS, Van Dael CM, Scheenstra R, Goorhuis JF, Sieders E, Verkade HJ, et al. Experience with molecular adsorbent recirculating system treatment in 20 children listed for high-urgency liver transplantation. Liver Transpl. 2015;21(3):369\u201380. https:\/\/doi.org\/10.1002\/lt.24037.","journal-title":"Liver Transpl"},{"issue":"5","key":"1224_CR38","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1111\/j.1528-1157.1988.tb03757.x","volume":"29","author":"D Scheffner","year":"1988","unstructured":"Scheffner D, Konig S, Rauterberg-Ruland I, Kochen W, Hofmann WJ, Unkelbach S. Fatal liver failure in 16 children with valproate therapy. Epilepsia. 1988;29(5):530\u201342. https:\/\/doi.org\/10.1111\/j.1528-1157.1988.tb03757.x.","journal-title":"Epilepsia"},{"issue":"3","key":"1224_CR39","doi-asserted-by":"publisher","first-page":"193","DOI":"10.3760\/cma.j.issn.1007-3418.2012.03.011","volume":"20","author":"SZ Wang","year":"2012","unstructured":"Wang SZ, Gao S, Liu YM, Huang YL, Chen YS, Wang XX, et al. Clinical characteristics of drug-induced liver injury in 31 pediatric cases. Chin J Hepatol. 2012;20(3):193\u20135. https:\/\/doi.org\/10.3760\/cma.j.issn.1007-3418.2012.03.011.","journal-title":"Chin J Hepatol."},{"issue":"1","key":"1224_CR40","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1007\/s13181-020-00804-5","volume":"17","author":"LC Epperson","year":"2021","unstructured":"Epperson LC, Weiss ST, Cao DJ. A case report of a severe, unusually delayed anaphylactoid reaction to intravenous N-acetylcysteine during treatment of acute acetaminophen toxicity in an adolescent. J Med Toxicol. 2021;17(1):75\u20139. https:\/\/doi.org\/10.1007\/s13181-020-00804-5.","journal-title":"J Med Toxicol"},{"key":"1224_CR41","doi-asserted-by":"publisher","unstructured":"Ng CT, Tan CK, Oh CC, Chang JP. Successful extracorporeal liver dialysis for the treatment of trimethoprim-sulfamethoxazole-induced fulminant hepatic failure. Singap Med J. 2013;54(5):e113\u20136. https:\/\/doi.org\/10.11622\/smedj.2013067.","DOI":"10.11622\/smedj.2013067"},{"issue":"10","key":"1224_CR42","doi-asserted-by":"publisher","first-page":"1910","DOI":"10.1097\/CCM.0000000000001826","volume":"44","author":"A Deep","year":"2016","unstructured":"Deep A, Stewart CE, Dhawan A, Douiri A. Effect of continuous renal replacement therapy on outcome in pediatric acute liver failure. Crit Care Med. 2016;44(10):1910\u20139. https:\/\/doi.org\/10.1097\/CCM.0000000000001826.","journal-title":"Crit Care Med"},{"issue":"3","key":"1224_CR43","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1111\/j.1365-2133.2006.07704.x","volume":"156","author":"SH Kardaun","year":"2007","unstructured":"Kardaun SH, Sidoroff A, Valeyrie-Allanore L, Halevy S, Davidovici BB, Mockenhaupt M, et al. Variability in the clinical pattern of cutaneous side-effects of drugs with systemic symptoms: does a DRESS syndrome really exist? Br J Dermatol. 2007;156(3):609\u201311. https:\/\/doi.org\/10.1111\/j.1365-2133.2006.07704.x.","journal-title":"Br J Dermatol"},{"key":"1224_CR44","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1016\/0016-5085(89)90081-4","volume":"97","author":"JG O\u2019Grady","year":"1989","unstructured":"O\u2019Grady JG, Alexander GJ, Hayllar KM, Williams R. Early indicators of prognosis in fulminant hepatic failure. Gastroenterology. 1989;97:439\u201345. https:\/\/doi.org\/10.1016\/0016-5085(89)90081-4.","journal-title":"Gastroenterology"},{"issue":"4","key":"1224_CR45","doi-asserted-by":"publisher","first-page":"648","DOI":"10.1002\/hep.1840060417","volume":"6","author":"J Bernuau","year":"1986","unstructured":"Bernuau J, Goudeau A, Poynard T, Dubois F, Lesage G, Yvonnet B, et al. Multivariate analysis of prognostic factors in fulminant hepatitis B. Hepatology. 1986;6(4):648\u201351. https:\/\/doi.org\/10.1002\/hep.1840060417.","journal-title":"Hepatology"},{"issue":"2","key":"1224_CR46","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1097\/MPG.0000000000002383","volume":"69","author":"F DiPaola","year":"2019","unstructured":"DiPaola F, Molleston JP, Gu J, Cirulli ET, Chalasani N, Barnhart H, et al. Antimicrobials and antiepileptics are the leading causes of idiosyncratic drug-induced liver injury in American children. J Pediatr Gastroenterol Nutr. 2019;69(2):152\u20139. https:\/\/doi.org\/10.1097\/MPG.0000000000002383.","journal-title":"J Pediatr Gastroenterol Nutr"},{"issue":"4","key":"1224_CR47","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1016\/j.anpedi.2012.06.012","volume":"78","author":"E Ocete Hita","year":"2013","unstructured":"Ocete Hita E, Martin Garcia JA, Gimenez Sanchez F, Flores Gonzalez JC, Abril Molina A, Salmeron Escobar J, et al. Hepatotoxicity due to drugs or natural products in children. An Pediatr (Barc). 2013;78(4):248\u201359. https:\/\/doi.org\/10.1016\/j.anpedi.2012.06.012.","journal-title":"An Pediatr (Barc)"},{"issue":"4","key":"1224_CR48","doi-asserted-by":"publisher","first-page":"1344","DOI":"10.1002\/hep.24527","volume":"54","author":"H Devarbhavi","year":"2011","unstructured":"Devarbhavi H, Karanth D, Prasanna KS, Adarsh CK, Patil M. Drug-Induced liver injury with hypersensitivity features has a better outcome: a single-center experience of 39 children and adolescents. Hepatology. 2011;54(4):1344\u201350. https:\/\/doi.org\/10.1002\/hep.24527.","journal-title":"Hepatology"},{"issue":"4","key":"1224_CR49","doi-asserted-by":"publisher","first-page":"525","DOI":"10.5009\/gnl14184","volume":"9","author":"Y Zhu","year":"2015","unstructured":"Zhu Y, Li YG, Wang JB, Liu SH, Wang LF, Zhao YL, et al. Causes, features, and outcomes of drug-induced liver injury in 69 children from China. Gut Liver. 2015;9(4):525\u201333. https:\/\/doi.org\/10.5009\/gnl14184.","journal-title":"Gut Liver."},{"issue":"2","key":"1224_CR50","doi-asserted-by":"publisher","first-page":"178","DOI":"10.2174\/1389200211314020005","volume":"14","author":"L Cuzzolin","year":"2013","unstructured":"Cuzzolin L, Antonucci R, Fanos V. Paracetamol (acetaminophen) efficacy and safety in the newborn. Curr Drug Metab. 2013;14(2):178\u201385. https:\/\/doi.org\/10.2174\/1389200211314020005.","journal-title":"Curr Drug Metab"},{"issue":"3","key":"1224_CR51","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1081\/clt-100100934","volume":"38","author":"EM Caravati","year":"2000","unstructured":"Caravati EM. Unintentional acetaminophen ingestion in children and the potential for hepatotoxicity. J Toxicol Clin Toxicol. 2000;38(3):291\u20136. https:\/\/doi.org\/10.1081\/clt-100100934.","journal-title":"J Toxicol Clin Toxicol"},{"issue":"1","key":"1224_CR52","doi-asserted-by":"publisher","first-page":"1","DOI":"10.2165\/00003088-200645010-00001","volume":"45","author":"S Bjorkman","year":"2006","unstructured":"Bjorkman S. Prediction of cytochrome p450-mediated hepatic drug clearance in neonates, infants and children: how accurate are available scaling methods? Clin Pharmacokinet. 2006;45(1):1\u201311. https:\/\/doi.org\/10.2165\/00003088-200645010-00001.","journal-title":"Clin Pharmacokinet"},{"issue":"2","key":"1224_CR53","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1016\/j.pharmthera.2008.02.005","volume":"118","author":"RN Hines","year":"2008","unstructured":"Hines RN. The ontogeny of drug metabolism enzymes and implications for adverse drug events. Pharmacol Ther. 2008;118(2):250\u201367. https:\/\/doi.org\/10.1016\/j.pharmthera.2008.02.005.","journal-title":"Pharmacol Ther"},{"key":"1224_CR54","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.curtheres.2014.12.001","volume":"77","author":"GM Pacifici","year":"2015","unstructured":"Pacifici GM, Allegaert K. Clinical pharmacology of paracetamol in neonates: a review. Curr Ther Res Clin Exp. 2015;77:24\u201330. https:\/\/doi.org\/10.1016\/j.curtheres.2014.12.001.","journal-title":"Curr Ther Res Clin Exp"},{"issue":"6","key":"1224_CR55","doi-asserted-by":"publisher","first-page":"612","DOI":"10.1111\/apa.12638","volume":"103","author":"C van Ganzewinkel","year":"2014","unstructured":"van Ganzewinkel C, Derijks L, Anand KJ, van Lingen RA, Neef C, Kramer BW, et al. Multiple intravenous doses of paracetamol result in a predictable pharmacokinetic profile in very preterm infants. Acta Paediatr. 2014;103(6):612\u20137. https:\/\/doi.org\/10.1111\/apa.12638.","journal-title":"Acta Paediatr"},{"issue":"8","key":"1224_CR56","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1097\/FPC.0000000000000150","volume":"25","author":"LL Mazaleuskaya","year":"2015","unstructured":"Mazaleuskaya LL, Sangkuhl K, Thorn CF, FitzGerald GA, Altman RB, Klein TE. PharmGKB summary: pathways of acetaminophen metabolism at the therapeutic versus toxic doses. Pharmacogenet Genom. 2015;25(8):416\u201326. https:\/\/doi.org\/10.1097\/FPC.0000000000000150.","journal-title":"Pharmacogenet Genom"},{"issue":"2","key":"1224_CR57","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1093\/toxsci\/kfaa002","volume":"174","author":"H Jaeschke","year":"2020","unstructured":"Jaeschke H, Akakpo JY, Umbaugh DS, Ramachandran A. Novel therapeutic approaches against acetaminophen-induced liver injury and acute liver failure. Toxicol Sci. 2020;174(2):159\u201367. https:\/\/doi.org\/10.1093\/toxsci\/kfaa002.","journal-title":"Toxicol Sci"},{"key":"1224_CR58","doi-asserted-by":"publisher","unstructured":"Lee WM, Hynan LS, Rossaro L, Fontana RJ, Stravitz RT, Larson AM, et al. Intravenous N-acetylcysteine improves transplant-free survival in early stage non-acetaminophen acute liver failure. Gastroenterology. 2009;137(3):856\u201364, 64 e1. https:\/\/doi.org\/10.1053\/j.gastro.2009.06.006.","DOI":"10.1053\/j.gastro.2009.06.006"},{"issue":"4","key":"1224_CR59","doi-asserted-by":"publisher","first-page":"1542","DOI":"10.1002\/hep.26001","volume":"57","author":"RH Squires","year":"2013","unstructured":"Squires RH, Dhawan A, Alonso E, Narkewicz MR, Shneider BL, Rodriguez-Baez N, et al. Intravenous N-acetylcysteine in pediatric patients with nonacetaminophen acute liver failure: a placebo-controlled clinical trial. Hepatology. 2013;57(4):1542\u20139. https:\/\/doi.org\/10.1002\/hep.26001.","journal-title":"Hepatology"},{"key":"1224_CR60","doi-asserted-by":"publisher","unstructured":"Chalasani NP, Maddur H, Russo MW, Wong RJ, Reddy KR, Practice parameters committee of the American College of Gastroenterology. ACG clinical guideline: diagnosis and management of idiosyncratic drug-induced liver injury. Am J Gastroenterol. 2021;116(5):878\u201398. https:\/\/doi.org\/10.14309\/ajg.0000000000001259.","DOI":"10.14309\/ajg.0000000000001259"},{"issue":"2","key":"1224_CR61","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1002\/hep.1840160213","volume":"16","author":"M Yoshikawa","year":"1992","unstructured":"Yoshikawa M, Tsujii T, Matsumura K, Yamao J, Matsumura Y, Kubo R, et al. Immunomodulatory effects of ursodeoxycholic acid on immune responses. Hepatology. 1992;16(2):358\u201364. https:\/\/doi.org\/10.1002\/hep.1840160213.","journal-title":"Hepatology"},{"issue":"11","key":"1224_CR62","doi-asserted-by":"publisher","first-page":"1661","DOI":"10.1016\/S0006-2952(02)01391-6","volume":"64","author":"D Lapenna","year":"2002","unstructured":"Lapenna D, Ciofani G, Festi D, Neri M, Pierdomenico SD, Giamberardino MA, et al. Antioxidant properties of ursodeoxycholic acid. Biochem Pharmacol. 2002;64(11):1661\u20137. https:\/\/doi.org\/10.1016\/S0006-2952(02)01391-6.","journal-title":"Biochem Pharmacol"},{"issue":"3","key":"1224_CR63","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1053\/jhep.2002.36088","volume":"36","author":"G Paumgartner","year":"2002","unstructured":"Paumgartner G, Beuers U. Ursodeoxycholic acid in cholestatic liver disease: mechanisms of action and therapeutic use revisited. Hepatology. 2002;36(3):525\u201331. https:\/\/doi.org\/10.1053\/jhep.2002.36088.","journal-title":"Hepatology"},{"key":"1224_CR64","first-page":"351","volume":"53","author":"M Asgarshirazi","year":"2015","unstructured":"Asgarshirazi M, Shariat M, Dalili H, Keihanidoost Z. Ursodeoxycholic acid can improve liver transaminase quantities in children with anticonvulsant drugs hepatotoxicity: a pilot study. Acta Med Iran. 2015;53:351\u20135.","journal-title":"Acta Med Iran"},{"issue":"4","key":"1224_CR65","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1016\/s1085-5629(96)80038-1","volume":"15","author":"H Bocquet","year":"1996","unstructured":"Bocquet H, Bagot M, Roujeau JC. Drug-induced pseudolymphoma and drug hypersensitivity syndrome (Drug Rash with Eosinophilia and Systemic Symptoms: DRESS). Semin Cutan Med Surg. 1996;15(4):250\u20137. https:\/\/doi.org\/10.1016\/s1085-5629(96)80038-1.","journal-title":"Semin Cutan Med Surg"},{"issue":"1","key":"1224_CR66","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1111\/pde.14446","volume":"38","author":"R Afiouni","year":"2021","unstructured":"Afiouni R, Zeinaty P, Kechichian E, Zoghaib S, Matar S, Helou-Mallat J, et al. Pediatric drug reaction with eosinophilia and systemic symptoms: a systematic review of the literature, with a focus on relapsing cases. Pediatr Dermatol. 2021;38(1):125\u201331. https:\/\/doi.org\/10.1111\/pde.14446.","journal-title":"Pediatr Dermatol"},{"key":"1224_CR67","doi-asserted-by":"publisher","unstructured":"Bedouelle E, Ben Said B, Tetart F, Milpied B, Welfringer-Morin A, Maruani A, et al. Drug reaction with eosinophilia and systemic symptoms (DRESS): series of 49 French pediatric cases. J Allergy Clin Immunol Pract. 2022;10(1):267\u201374 e5. https:\/\/doi.org\/10.1016\/j.jaip.2021.07.025.","DOI":"10.1016\/j.jaip.2021.07.025"},{"issue":"6","key":"1224_CR68","doi-asserted-by":"publisher","first-page":"1604","DOI":"10.1002\/cpt.2423","volume":"110","author":"A Cueto-Sanchez","year":"2021","unstructured":"Cueto-Sanchez A, Niu H, Del Campo-Herrera E, Robles-Diaz M, Sanabria-Cabrera J, Ortega-Alonso A, et al. Lymphocyte profile and immune checkpoint expression in drug-induced liver injury: an immunophenotyping study. Clin Pharmacol Ther. 2021;110(6):1604\u201312. https:\/\/doi.org\/10.1002\/cpt.2423.","journal-title":"Clin Pharmacol Ther"},{"issue":"1","key":"1224_CR69","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1186\/1710-1492-9-30","volume":"9","author":"D Liu","year":"2013","unstructured":"Liu D, Ahmet A, Ward L, Krishnamoorthy P, Mandelcorn ED, Leigh R, et al. A practical guide to the monitoring and management of the complications of systemic corticosteroid therapy. Allergy Asthma Clin Immunol. 2013;9(1):30. https:\/\/doi.org\/10.1186\/1710-1492-9-30.","journal-title":"Allergy Asthma Clin Immunol"},{"issue":"4","key":"1224_CR70","doi-asserted-by":"publisher","first-page":"1238","DOI":"10.1016\/j.jaip.2017.10.016","volume":"6","author":"N Marcus","year":"2018","unstructured":"Marcus N, Smuel K, Almog M, Prais D, Straussberg R, Landau D, et al. Successful intravenous immunoglobulin treatment in pediatric severe DRESS syndrome. J Allergy Clin Immunol Pract. 2018;6(4):1238\u201342. https:\/\/doi.org\/10.1016\/j.jaip.2017.10.016.","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"4","key":"1224_CR71","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1186\/cc2895","volume":"8","author":"M Boyle","year":"2004","unstructured":"Boyle M, Kurtovic J, Bihari D, Riordan S, Steiner C. Equipment review: the molecular adsorbents recirculating system (MARS). Crit Care. 2004;8(4):280\u20136. https:\/\/doi.org\/10.1186\/cc2895.","journal-title":"Crit Care"},{"issue":"10","key":"1224_CR72","first-page":"17046","volume":"8","author":"GL He","year":"2015","unstructured":"He GL, Feng L, Duan CY, Hu X, Zhou CJ, Cheng Y, et al. Meta-analysis of survival with the molecular adsorbent recirculating system for liver failure. Int J Clin Exp Med. 2015;8(10):17046\u201354.","journal-title":"Int J Clin Exp Med"},{"issue":"2","key":"1224_CR73","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1002\/lt.24966","volume":"24","author":"J Quintero Bernabeu","year":"2018","unstructured":"Quintero Bernabeu J, Ortega Lopez J, Juamperez Goni J, Julio Tatis E, Mercadal-Hally M, Bilbao Aguirre I, et al. The role of molecular adsorbent recirculating system in pediatric acute liver failure. Liver Transpl. 2018;24(2):308\u201310. https:\/\/doi.org\/10.1002\/lt.24966.","journal-title":"Liver Transpl"},{"issue":"5","key":"1224_CR74","doi-asserted-by":"publisher","first-page":"1119","DOI":"10.1007\/s00467-020-04613-4","volume":"36","author":"BS Zoica","year":"2021","unstructured":"Zoica BS, Deep A. Extracorporeal renal and liver support in pediatric acute liver failure. Pediatr Nephrol. 2021;36(5):1119\u201328. https:\/\/doi.org\/10.1007\/s00467-020-04613-4.","journal-title":"Pediatr Nephrol"},{"issue":"11","key":"1224_CR75","doi-asserted-by":"publisher","first-page":"2427","DOI":"10.1007\/s00467-019-04319-2","volume":"34","author":"R Raina","year":"2019","unstructured":"Raina R, Grewal MK, Blackford M, Symons JM, Somers MJG, Licht C, et al. Renal replacement therapy in the management of intoxications in children: recommendations from the Pediatric Continuous Renal Replacement Therapy (PCRRT) workgroup. Pediatr Nephrol. 2019;34(11):2427\u201348. https:\/\/doi.org\/10.1007\/s00467-019-04319-2.","journal-title":"Pediatr Nephrol"},{"key":"1224_CR76","unstructured":"Valproate. LiverTox: clinical and research information on drug-induced liver injury. 2020. https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK548284\/. Accessed 16 July 2022."},{"issue":"5","key":"1224_CR77","doi-asserted-by":"publisher","first-page":"1791","DOI":"10.1002\/hep.23891","volume":"52","author":"JD Stewart","year":"2010","unstructured":"Stewart JD, Horvath R, Baruffini E, Ferrero I, Bulst S, Watkins PB, et al. Polymerase gamma gene POLG determines the risk of sodium valproate-induced liver toxicity. Hepatology. 2010;52(5):1791\u20136. https:\/\/doi.org\/10.1002\/hep.23891.","journal-title":"Hepatology"},{"issue":"6","key":"1224_CR78","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1111\/epi.13011","volume":"56","author":"T Budi","year":"2015","unstructured":"Budi T, Toth K, Nagy A, Szever Z, Kiss A, Temesvari M, et al. Clinical significance of CYP2C9-status guided valproic acid therapy in children. Epilepsia. 2015;56(6):849\u201355. https:\/\/doi.org\/10.1111\/epi.13011.","journal-title":"Epilepsia"},{"issue":"12","key":"1224_CR79","doi-asserted-by":"publisher","first-page":"1009","DOI":"10.1038\/jhg.2017.91","volume":"62","author":"MM Zhu","year":"2017","unstructured":"Zhu MM, Li HL, Shi LH, Chen XP, Luo J, Zhang ZL. The pharmacogenomics of valproic acid. J Hum Genet. 2017;62(12):1009\u201314. https:\/\/doi.org\/10.1038\/jhg.2017.91.","journal-title":"J Hum Genet"},{"issue":"2","key":"1224_CR80","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1097\/MOP.0b013e32805e879a","volume":"19","author":"S Russell","year":"2007","unstructured":"Russell S. Carnitine as an antidote for acute valproate toxicity in children. Curr Opin Pediatr. 2007;19(2):206\u201310. https:\/\/doi.org\/10.1097\/MOP.0b013e32805e879a.","journal-title":"Curr Opin Pediatr"},{"issue":"2","key":"1224_CR81","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1080\/15563650902752376","volume":"47","author":"PE Lheureux","year":"2009","unstructured":"Lheureux PE, Hantson P. Carnitine in the treatment of valproic acid-induced toxicity. Clin Toxicol (Phila). 2009;47(2):101\u201311. https:\/\/doi.org\/10.1080\/15563650902752376.","journal-title":"Clin Toxicol (Phila)"},{"issue":"6","key":"1224_CR82","doi-asserted-by":"publisher","first-page":"867","DOI":"10.1038\/clpt.2011.47","volume":"89","author":"KE Price","year":"2011","unstructured":"Price KE, Pearce RE, Garg UC, Heese BA, Smith LD, Sullivan JE, et al. Effects of valproic acid on organic acid metabolism in children: a metabolic profiling study. Clin Pharmacol Ther. 2011;89(6):867\u201374. https:\/\/doi.org\/10.1038\/clpt.2011.47.","journal-title":"Clin Pharmacol Ther"},{"issue":"11","key":"1224_CR83","doi-asserted-by":"publisher","first-page":"1216","DOI":"10.1111\/j.1528-1157.1998.tb01315.x","volume":"39","author":"DC De Vivo","year":"1998","unstructured":"De Vivo DC, Bohan TP, Coulter DL, Dreifuss FE, Greenwood RS, Nordli DR, et al. L-carnitine supplementation in childhood epilepsy: current perspectives. Epilepsia. 1998;39(11):1216\u201325. https:\/\/doi.org\/10.1111\/j.1528-1157.1998.tb01315.x.","journal-title":"Epilepsia"},{"issue":"12","key":"1224_CR84","doi-asserted-by":"publisher","first-page":"967","DOI":"10.1177\/0960327107087799","volume":"26","author":"YC Chan","year":"2007","unstructured":"Chan YC, Tse ML, Lau FL. Two cases of valproic acid poisoning treated with L-carnitine. Hum Exp Toxicol. 2007;26(12):967\u20139. https:\/\/doi.org\/10.1177\/0960327107087799.","journal-title":"Hum Exp Toxicol"},{"issue":"3","key":"1224_CR85","doi-asserted-by":"publisher","first-page":"e344","DOI":"10.1097\/MJT.0000000000000706","volume":"26","author":"M Glatstein","year":"2019","unstructured":"Glatstein M, Bonifacio Rino P, de Pinho S, Scolnik D, Pivko-Levi D, Hoyte C. Levocarnitine for the treatment of valproic acid-induced hyperammonemic encephalopathy in children: the experience of a large, tertiary care pediatric hospital and a poison center. Am J Ther. 2019;26(3):e344\u20139. https:\/\/doi.org\/10.1097\/MJT.0000000000000706.","journal-title":"Am J Ther"},{"key":"1224_CR86","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1016\/j.phrs.2019.04.025","volume":"144","author":"X Li","year":"2019","unstructured":"Li X, Sun R, Liu R. Natural products in licorice for the therapy of liver diseases: progress and future opportunities. Pharmacol Res. 2019;144:210\u201326. https:\/\/doi.org\/10.1016\/j.phrs.2019.04.025.","journal-title":"Pharmacol Res"},{"key":"1224_CR87","unstructured":"Tang LN, Lin F, Sen Z, Sun YY, Yao Y. Magnesium isoglycyrrhizinate used in the treatment of chemotherapeutic drugs-induced acute liver dysfunction: a phase III clinical trial. TUMOR. 2012;738\u201343."},{"issue":"11","key":"1224_CR88","doi-asserted-by":"publisher","first-page":"2102","DOI":"10.1111\/liv.14204","volume":"39","author":"Y Wang","year":"2019","unstructured":"Wang Y, Wang Z, Gao M, Zhong H, Chen C, Yao Y, et al. Efficacy and safety of magnesium isoglycyrrhizinate injection in patients with acute drug-induced liver injury: a phase II trial. Liver Int. 2019;39(11):2102\u201311. https:\/\/doi.org\/10.1111\/liv.14204.","journal-title":"Liver Int"},{"key":"1224_CR89","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2020.105404","volume":"164","author":"H Niu","year":"2021","unstructured":"Niu H, Sanabria-Cabrera J, Alvarez-Alvarez I, Robles-Diaz M, Stankeviciute S, Aithal GP, et al. Prevention and management of idiosyncratic drug-induced liver injury: systematic review and meta-analysis of randomised clinical trials. Pharmacol Res. 2021;164: 105404. https:\/\/doi.org\/10.1016\/j.phrs.2020.105404.","journal-title":"Pharmacol Res"},{"key":"1224_CR90","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.fct.2013.07.008","volume":"60","author":"Y Chen","year":"2013","unstructured":"Chen Y, Dong H, Thompson DC, Shertzer HG, Nebert DW, Vasiliou V. Glutathione defense mechanism in liver injury: insights from animal models. Food Chem Toxicol. 2013;60:38\u201344. https:\/\/doi.org\/10.1016\/j.fct.2013.07.008.","journal-title":"Food Chem Toxicol"},{"issue":"8","key":"1224_CR91","doi-asserted-by":"publisher","first-page":"300060521103981","DOI":"10.1177\/03000605211039810","volume":"49","author":"X Lei","year":"2021","unstructured":"Lei X, Zhang J, Xu Q, Li J, Qian Y, Zhang J, et al. Exploring the efficacy and safety of polyene phosphatidylcholine for treatment of drug-induced liver injury using the Roussel Uclaf causality assessment method: a propensity score matching comparison. J Int Med Res. 2021;49(8):3000605211039810. https:\/\/doi.org\/10.1177\/03000605211039810.","journal-title":"J Int Med Res"},{"issue":"2","key":"1224_CR92","first-page":"136","volume":"24","author":"SS Zhu","year":"2010","unstructured":"Zhu SS, Dong Y, Gan Y, Tang HM, Xu ZQ, Chen DW, et al. Efficacy and safety of ademetionine for treatment of drug-induced liver disease in children. Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi. 2010;24(2):136\u20138.","journal-title":"Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi"},{"key":"1224_CR93","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2022.828565","volume":"13","author":"A Licata","year":"2022","unstructured":"Licata A, Minissale MG, Stankevi\u010di\u016bt\u0117 S, Sanabria-Cabrera J, Lucena MI, Andrade RJ, et al. N-Acetylcysteine for preventing acetaminophen-induced liver injury: a comprehensive review. Front Pharmacol. 2022;13: 828565. https:\/\/doi.org\/10.3389\/fphar.2022.828565.","journal-title":"Front Pharmacol"},{"key":"1224_CR94","doi-asserted-by":"crossref","unstructured":"Peire MA, Lucena MI, Ruiz-Extremera A, Jara P, Romero-Gonzalez J, Andrade RJ. Drug-induced hepatotoxicity in children. Where we are and where we are going. An Esp Pediatr. 2002;56(5):434\u201342.","DOI":"10.1016\/S1695-4033(02)77841-7"},{"key":"1224_CR95","unstructured":"Handbook for grading the quality of evidence and the strength of recommendations using the GRADE approach. 2013. https:\/\/gdt.gradepro.org\/app\/handbook\/handbook.html. Accessed 12 July 2022."}],"container-title":["Drug Safety"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40264-022-01224-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40264-022-01224-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40264-022-01224-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,13]],"date-time":"2022-10-13T15:55:00Z","timestamp":1665676500000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40264-022-01224-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8,25]]},"references-count":95,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2022,11]]}},"alternative-id":["1224"],"URL":"https:\/\/doi.org\/10.1007\/s40264-022-01224-w","relation":{},"ISSN":["0114-5916","1179-1942"],"issn-type":[{"value":"0114-5916","type":"print"},{"value":"1179-1942","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,8,25]]},"assertion":[{"value":"4 August 2022","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 August 2022","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The present study has been supported by grants from Instituto de Salud Carlos III (ISCIII) cofounded by Fondo Europeo de Desarrollo Regional-FEDER (contract numbers: PI21\/01248; PT20\/000127), Consejer\u00eda de Salud de Junta de Andaluc\u00eda (contract number: PI-0310-2018), and Agencia Espa\u00f1ola del Medicamento. CIBERehd and Plataforma ISCIII Ensayos Cl\u00ednicos are funded by ISCIII. HN holds a postdoctoral research contract funded by Junta de Andalucia (POSTDOC_21_00780). I.A.-A. holds a Sara Borrell contract funded by ISCIII (CD20\/00083). This article\/publication is based upon work from COST Action \"CA17112\u00a0- Prospective European Drug-Induced Liver Injury Network\", supported by COST (European Cooperation in Science and Technology) . The funding sources have no involvement in study design; in the collection, analysis, and interpretation of data; in the writing of the report; and in the decision to submit the article for publication.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Funding"}},{"value":"The authors declare that they have no conflict of interest.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Not applicable. No ethical approval was needed because data were retrieved from previous published studies in which informed consent was obtained by the primary investigators.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Not applicable.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Not applicable.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Data sharing is not applicable to this article as no datasets were generated or analysed during the current study.","order":7,"name":"Ethics","group":{"name":"EthicsHeading","label":"Availability of data and material (data transparency)"}},{"value":"Not applicable.","order":8,"name":"Ethics","group":{"name":"EthicsHeading","label":"Code availability"}},{"value":"HN (conceptualization, data curation, writing\u2014original draft); EA (conceptualization, data curation, writing\u2014original draft); IA-A (conceptualization, data curation, writing\u2014original draft); IM-C (writing\u2014review and editing); GPA (writing\u2014review and editing); CA (writing\u2014review and editing), RJA (conceptualization, writing\u2014review and editing); MIL (conceptualization, writing\u2014review and editing). All authors have read and approved the final version of the manuscript.","order":9,"name":"Ethics","group":{"name":"EthicsHeading","label":"Author\u2019s contribution"}}]}}